These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
692 related items for PubMed ID: 25270067
21. The Role of TLR4 on PGC-1α-Mediated Oxidative Stress in Tubular Cell in Diabetic Kidney Disease. Yuan S, Liu X, Zhu X, Qu Z, Gong Z, Li J, Xiao L, Yang Y, Liu H, Sun L, Liu F. Oxid Med Cell Longev; 2018; 2018():6296802. PubMed ID: 29861832 [Abstract] [Full Text] [Related]
23. Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway. Sharma I, Liao Y, Zheng X, Kanwar YS. JCI Insight; 2022 Mar 22; 7(6):. PubMed ID: 35315361 [Abstract] [Full Text] [Related]
24. DUSP1 overexpression attenuates renal tubular mitochondrial dysfunction by restoring Parkin-mediated mitophagy in diabetic nephropathy. Lu C, Wu B, Liao Z, Xue M, Zou Z, Feng J, Sheng J. Biochem Biophys Res Commun; 2021 Jun 25; 559():141-147. PubMed ID: 33940385 [Abstract] [Full Text] [Related]
25. Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy. Lee YH, Kim SH, Kang JM, Heo JH, Kim DJ, Park SH, Sung M, Kim J, Oh J, Yang DH, Lee SH, Lee SY. Am J Physiol Renal Physiol; 2019 Oct 01; 317(4):F767-F780. PubMed ID: 31390268 [Abstract] [Full Text] [Related]
26. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway. Zhang Q, He L, Dong Y, Fei Y, Wen J, Li X, Guan J, Liu F, Zhou T, Li Z, Fan Y, Wang N. FASEB J; 2020 Jun 01; 34(6):7500-7519. PubMed ID: 32281218 [Abstract] [Full Text] [Related]
27. VDR regulates mitochondrial function as a protective mechanism against renal tubular cell injury in diabetic rats. Chen H, Zhang H, Li AM, Liu YT, Liu Y, Zhang W, Yang C, Song N, Zhan M, Yang S. Redox Biol; 2024 Apr 01; 70():103062. PubMed ID: 38320454 [Abstract] [Full Text] [Related]
28. RUNX3 alleviates mitochondrial dysfunction and tubular damage by inhibiting TLR4/NF-κB signalling pathway in diabetic kidney disease. Xiao L, Ye G. Nephrology (Carlton); 2024 Aug 01; 29(8):470-481. PubMed ID: 38735649 [Abstract] [Full Text] [Related]
29. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response. Liu Y, Zhang L, Zhang S, Liu J, Li X, Yang K, Yang D, Liu Y, Sun L, Liu F, Xiao L. Mol Med; 2023 Apr 24; 29(1):57. PubMed ID: 37095454 [Abstract] [Full Text] [Related]
30. p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Sun L, Xiao L, Nie J, Liu FY, Ling GH, Zhu XJ, Tang WB, Chen WC, Xia YC, Zhan M, Ma MM, Peng YM, Liu H, Liu YH, Kanwar YS. Am J Physiol Renal Physiol; 2010 Nov 24; 299(5):F1014-25. PubMed ID: 20739391 [Abstract] [Full Text] [Related]
31. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Chen K, Dai H, Yuan J, Chen J, Lin L, Zhang W, Wang L, Zhang J, Li K, He Y. Cell Death Dis; 2018 Jan 24; 9(2):105. PubMed ID: 29367621 [Abstract] [Full Text] [Related]
32. Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. Taneda S, Honda K, Tomidokoro K, Uto K, Nitta K, Oda H. Am J Physiol Renal Physiol; 2010 Dec 24; 299(6):F1451-61. PubMed ID: 20844021 [Abstract] [Full Text] [Related]
34. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Han YC, Tang SQ, Liu YT, Li AM, Zhan M, Yang M, Song N, Zhang W, Wu XQ, Peng CH, Zhang H, Yang S. Cell Death Dis; 2021 Oct 09; 12(10):925. PubMed ID: 34628484 [Abstract] [Full Text] [Related]
35. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells. Zhu Z, Luan G, Peng S, Fang Y, Fang Q, Shen S, Wu K, Qian S, Jia W, Ye J, Wei L. Phytomedicine; 2023 Oct 09; 119():154975. PubMed ID: 37517171 [Abstract] [Full Text] [Related]
36. A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells. Liu J, Yang K, Zhou L, Deng J, Rong G, Shi L, Zhang X, Ren J, Zhang Y, Cao W. Int Immunopharmacol; 2024 Nov 15; 141():112794. PubMed ID: 39137626 [Abstract] [Full Text] [Related]
37. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Sharma I, Deng F, Kanwar YS. Biomedicines; 2020 Jul 16; 8(7):. PubMed ID: 32708636 [Abstract] [Full Text] [Related]
38. Expression of myo-inositol oxygenase in tissues susceptible to diabetic complications. Arner RJ, Prabhu KS, Krishnan V, Johnson MC, Reddy CC. Biochem Biophys Res Commun; 2006 Jan 20; 339(3):816-20. PubMed ID: 16332355 [Abstract] [Full Text] [Related]
39. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. Livingston MJ, Wang J, Zhou J, Wu G, Ganley IG, Hill JA, Yin XM, Dong Z. Autophagy; 2019 Dec 20; 15(12):2142-2162. PubMed ID: 31066324 [Abstract] [Full Text] [Related]
40. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy. Chen K, Feng L, Hu W, Chen J, Wang X, Wang L, He Y. FASEB J; 2019 Mar 20; 33(3):4571-4585. PubMed ID: 30571313 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]